Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
With
Genentech, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant must be at least 18 years old
Participant must have been diagnosed with a recurrent brain tumor by magnetic resonance imaging (MRI) scan
Participant must be willing to practice adequate contraception
Participant must be able to swallow the enzastaurin tablets whole and receive bevacizumab intravenously
Participant must agree to use the study drug only as instructed by your study doctor and staff.
You may not be if
Women who are pregnant or breastfeeding
Participants who have significant heart, liver, kidney, or psychiatric disease
Participants who have an active infection
Participants who have any recent bleeding in the brain
Participants who are taking any anti-coagulation or anti-platelet medication \[including aspirin, non-steroidal anti-inflammatories, Cyclooxygenase-2 (COX-2) inhibitors\]
